Karen Wagner (L) and Joël Jean-Mairet (Ysios)
May 26, 2021 08:31 AM EDT
Financing

Eight bets in, Spain's Ys­ios of­fi­cial­ly ties a bow around €216M fund

Amber Tong

Hav­ing played a part in pi­o­neer­ing biotech ven­ture in­vest­ing in Spain, Ys­ios Bio­Fund has closed its third and largest fund to keep push­ing the en­ve­lope …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times